• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.

作者信息

Faber Lothar, Welge Dirk, Fassbender Dieter, Schmidt Henning K, Horstkotte Dieter, Seggewiss Hubert

机构信息

Department of Cardiology, Heart and Diabetes Center NRW, Ruhr-University Bochum, Georgstr. 11, D-32545 Bad Oeynhausen, Germany.

出版信息

Int J Cardiol. 2007 Jul 10;119(2):163-7. doi: 10.1016/j.ijcard.2006.07.179. Epub 2006 Oct 24.

DOI:10.1016/j.ijcard.2006.07.179
PMID:17067708
Abstract

AIM

To provide tools for predicting the course of AV conduction disturbances after ethanol-induced septal ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM).

METHODS AND RESULTS

Based on a scoring system developed 1996-1998 and including parameters from baseline ECG, heart rate profile, severity of outflow obstruction (LVOTO), peri-interventional enzyme kinetics, and peri-interventional conduction problems, the risk of permanent AV block following PTSMA was assessed in 155 consecutive HOCM patients (pts.; mean age: 53+/-13 years) between 1999 and 2004. During PTSMA with 2.1+/-0.5 ml of ethanol, transient complete AV block occurred in 71 pts. (46%). Pts. were grouped into a low, intermediate, and high risk group for permanent conduction damage, and treated accordingly (early discharge from monitoring, prolonged monitoring, early DDD-PM implantation). Permanent pacing was necessary in 11 cases (7%), 0/116 of these (0%) in the low, 4/31 (13%) in the intermediate, and 7/8 (87%) in the high-risk group. While a new right bundle branch block was the most frequent ECG finding after PTSMA, a left bundle branch block at baseline was associated with 4 of the 11 DDD-PM implantations (p<0.0001). In-hospital mortality was 0%, short-term (3-months) follow up was complete. During follow-up, AV conduction recovered in 4 pts. (46%) with a DDD-PM. New onset AV blocks did not occur. Significant improvement of symptoms was reported by 141 pts. (91%).

CONCLUSIONS

Catheter-based septal ablation is an effective non-surgical technique for reducing symptoms and outflow gradients in HOCM. The proposed scoring system appears to reliably discriminate pts. with a high risk for permanent PM dependency from those with stable AV conduction after PTSMA. Pts. with left bundle branch block at baseline should undergo DDD-PM implantation prior to ablation.

摘要

相似文献

1
Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.
Int J Cardiol. 2007 Jul 10;119(2):163-7. doi: 10.1016/j.ijcard.2006.07.179. Epub 2006 Oct 24.
2
[Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy].[预测梗阻性肥厚型心肌病经皮室间隔消融术后房室传导病变的风险]
Z Kardiol. 2003 Jan;92(1):39-47. doi: 10.1007/s00392-003-0878-7.
3
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].[经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:66例患者的急性结果及心肌对比超声心动图分析]
Z Kardiol. 1998 Mar;87(3):191-201. doi: 10.1007/s003920050171.
4
Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.超声心动图引导下经皮室间隔消融治疗症状性肥厚型梗阻性心肌病:7年经验
Eur J Echocardiogr. 2004 Oct;5(5):347-55. doi: 10.1016/j.euje.2004.01.001.
5
Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者手术心肌切除术失败后行经皮室间隔消融术。
Clin Res Cardiol. 2008 Dec;97(12):899-904. doi: 10.1007/s00392-008-0707-0. Epub 2008 Sep 5.
6
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.经皮腔内室间隔心肌消融术治疗肥厚型梗阻性心肌病:25例患者的急性结果及3个月随访
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
7
Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病经皮室间隔消融术后的长期随访
Clin Res Cardiol. 2007 Dec;96(12):856-63. doi: 10.1007/s00392-007-0579-8. Epub 2007 Sep 27.
8
One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.312例症状性肥厚型梗阻性心肌病患者经皮室间隔消融术的一年随访:血流动力学和临床反应的预测因素
Clin Res Cardiol. 2007 Dec;96(12):864-73. doi: 10.1007/s00392-007-0578-9. Epub 2007 Sep 25.
9
Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.肥厚型梗阻性心肌病经皮腔内室间隔心肌消融术的并发症
Chin Med J (Engl). 2002 Sep;115(9):1283-6.
10
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].[经皮腔内室间隔心肌消融术治疗肥厚性梗阻性心肌病]
Zhonghua Nei Ke Za Zhi. 2006 Mar;45(3):210-2.

引用本文的文献

1
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024.肥厚型心肌病诊断与治疗指南 - 2024
Arq Bras Cardiol. 2024 Jul 26;121(7):e202400415. doi: 10.36660/abc.20240415.
2
Haemodynamic Interplay Between Concomitant Left Ventricular Outflow Tract Obstruction and Aortic Stenosis.左心室流出道梗阻与主动脉瓣狭窄并存时的血流动力学相互作用
Interv Cardiol. 2021 Jun 10;16:e11. doi: 10.15420/icr.2020.36. eCollection 2021 Apr.
3
Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA).
酒精性右束支传导阻滞与肥厚型梗阻性心肌病(HOCM)酒精间隔消融术(ASA)后的良性预后相关。
Clin Res Cardiol. 2022 Feb;111(2):175-185. doi: 10.1007/s00392-021-01847-6. Epub 2021 Mar 26.
4
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.酒精间隔消融术与室间隔心肌切除术治疗梗阻性肥厚型心肌病:一项系统评价和荟萃分析
J Clin Med. 2020 Sep 23;9(10):3062. doi: 10.3390/jcm9103062.
5
Retrospective Analysis of Risk Factors for Related Complications of Chemical Ablation on Hypertrophic Obstructive Cardiomyopathy.肥厚型梗阻性心肌病化学消融相关并发症危险因素的回顾性分析。
Arq Bras Cardiol. 2019 Apr;112(4):432-438. doi: 10.5935/abc.20190060. Epub 2019 Apr 1.
6
The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.肥厚型心肌病的室间隔心肌切除术和酒精室间隔消融术对心脏传导系统的影响。
J Interv Card Electrophysiol. 2018 Aug;52(3):403-408. doi: 10.1007/s10840-018-0433-0. Epub 2018 Aug 10.
7
Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.经皮间隔心肌消融术治疗梗阻性肥厚型心肌病患者的风险标志物谱。
Clin Res Cardiol. 2018 Jun;107(6):479-486. doi: 10.1007/s00392-018-1209-3. Epub 2018 Feb 16.
8
Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.肥厚性梗阻性心肌病酒精间隔消融二十年
Curr Cardiol Rev. 2016;12(4):285-296. doi: 10.2174/1573403x11666150107160344.
9
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.酒精间隔消融术治疗肥厚性梗阻性心肌病——8年随访
Indian Heart J. 2014 Jan-Feb;66(1):57-63. doi: 10.1016/j.ihj.2013.12.008. Epub 2013 Dec 25.
10
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.药物难治性或药物不耐受性肥厚型心肌病的起搏治疗
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008523. doi: 10.1002/14651858.CD008523.pub2.